A review of ERGIC-53: Its structure, functions, regulation and relations with diseases

Histology and Histopathology

Volumn 24, Issue 9, 2009, Pages 1193-1204

  Zhang, Yong Ci ^a   Zhou, Yuan ^a   Yang, Chun Zheng ^a   Xiong, Dong Sheng ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

ERGIC 53; F5F8D; MCFD2

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; GLYCOPROTEIN; LMAN1 PROTEIN, HUMAN; MANNOSE BINDING LECTIN; MCFD2 PROTEIN, HUMAN; MEMBRANE PROTEIN; SIGNAL PEPTIDE; VESICULAR TRANSPORT PROTEIN;

BLOOD CLOTTING DISORDER; CHEMISTRY; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; GENETICS; GOLGI COMPLEX; METABOLISM; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT; RECESSIVE GENE; REVIEW;

BLOOD COAGULATION DISORDERS, INHERITED; ENDOPLASMIC RETICULUM; FACTOR V; FACTOR VIII; GENE EXPRESSION REGULATION; GENES, RECESSIVE; GLYCOPROTEINS; GOLGI APPARATUS; MANNOSE-BINDING LECTINS; MEMBRANE PROTEINS; PROTEIN BINDING; PROTEIN SORTING SIGNALS; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; VESICULAR TRANSPORT PROTEINS;

EID: 70349768393     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Adamian L. and Liang J. (2001). Helix-helix packing and interfacial pairwise interactions of residues in membrane proteins. J. Mol. Biol. 311, 891-907.
2. Andersson H., Kappeler F. and Hauri H.P. (1999). Protein targeting to endoplasmic reticulum by dilysine signals involves direct retention in addition to retrieval. J. Biol. Chem. 274, 15080-15084.
3. Appenzeller-Herzog C., Andersson H., Kappeler F, and Hauri H.P. (1999). The lectin ERGIC-53 is a cargo transport receptor for glycoproteins. Nat. Cell Biol. 1, 330-334.
4. Appenzeller-Herzog C., Roche A.C., Nufer O. and Hauri H.P. (2004). pH-indced conversion of the transport lectin ERGIC-53 triggers glycoprotein release. J. Biol. Chem. 279, 12943-12950.
5. Appenzeller-Herzog C., Nyfeler B., Burkhard P., Santamaria I., Lopez-Otin C. and Hauri H.P. (2005). Carbohydrate-and conformationdependent cargo capture for ER-exit. Mol. Biol. Cell 16, 1258-1267.
6. Arar C., Carpentier V., Le Caer J.P., Monsigny M., Legrand A. and Roche A.C. (1995). ERGIC-53, a membrane protein of the endoplasmic reticulum-Golgi intermediate compartment, is identical to MR60, an intracellular mannose-specific lectin of myelomonocytic cells. J. Biol. Chem. 270, 3551-3553.
7. Cabral C.M., Liu Y. and Sifers R.N. (2001). Dissecting glycoprotein quality control in the secretory pathway. Trends Biochem. Sci. 26, 619-624.
8. Dansako H., Ishimaru F., Takai Y., Tomoda J., Nakase K., Fujii K., Ogama Y., Kozuka T., Sezaki N., Honda K. and Harada M. (2001). Molecular characterization of the ERGIC-53 gene in two Japanese patients with combined factor V-factor VIII deficiency. Ann. Hematol. 80, 292-294.
9. Eilers M., Shekar S.C., Shieh T., Smith S.O. and Fleming P.J. (2000). Internal packing of helical membrane proteins. Proc. Natl. Acad. Sci. USA 97, 5796-5801.
10. Farmaki T., Ponnambalan S., Prescott A.R., Clausen H., Tang B.L., Hong W. and Lucocq J. (1999). Forward and retrograde trafficking in mitotic animal cells. ER-Golgi transport arrest restricts protein export from the ER into COPII-coated structures. J. Cell Sci. 112, 589-600.
11. Figueiredo P.D., Drecktrah D., Polizotto R.S., Cole N.B., Lippincott-Schwartz J. and Brown W.J. (2000). Phospholipase A2 antagonists inhibit constitutive retrograde membrane traffic to the endoplasmic reticulum. Traffic 1, 504-511.
12. Fraldi A., Zito E., Annunziata F., Lombardi A., Cozzolino M., Monti M., Spampanato C., Ballabio A., Pucci P., Sitia R. and Cosma M.P. (2008). Multistep, sequential control of the trafficking and function of the multiple sulfatase deficiency gene product, SUMF1 by PDI, ERGIC-53 and ERp44. Hum. Mol. Genet. 17, 2610-2621.
13. Frenkel Z., Gregory W., Kornfeld S. and Lederkremer G.Z. (2003). Endoplasmic reticulum-associated degradation of mammalian glycoproteins involves sugar chain trimming to Man6-5GlcNAc2. J. Biol. Chem. 278, 34119-34124.
14. Fujiwara T., Misumi Y. and Ikehara Y. (1998). Dynamic recycling of ERGIC-53 between the endoplasmic reticulum and the Golgi complex is disrupted by nordihydroguaiaretic acid. Biochem. Biophys. Res. Commun. 253, 869-876.
15. Guy J.E., Wigren E., Svärd M., Härd T. and Lindqvist Y. (2008). New insights into multiple coagulation factor deficiency from the solution structure of human MCFD2. J. Mol. Biol. 381, 941-955.
16. Hauri H.P., Appenzeller-Herzog C., Kuhn F. and Nufer O. (2000a). Lectins and traffic in the secretory pathway. FEBS Lett. 476, 32-37.
17. Hauri H.P., Kappeler F., Andersson H. and Appenzeller-Herzog C. (2000b). ERGIC-53 and traffic in the secretory pathway. J. Cell Sci. 113, 587-596.
18. Hirao K., Natsuka Y., Tamura T., Wada I., Morito D., Natsuka S., Romero P., Sleno B., Tremblay L.O., Herscovics A., Nagata K. and Hosokawa N. (2006). EDEM3, a soluble EDEM homolog, enhances glycoprotein endoplasmic reticulum-associated degradation and mannose trimming. J. Biol. Chem. 281, 9650-9658.
19. Hosokawa N., Tremblay L.O., You Z.P., Herscovics A., Wada I. and Nagata K. (2003). Enhancement of endoplasmic reticulum (ER) degradation of misfolded null Hong Kong a1-antitrypsin by human ER mannosidase. J. Biol. Chem. 278, 26287-26294.
20. Itin C., Kappeler F., Linstedt A.D. and Hauri H.P. (1995). A novel endocytosis signal related to the KKXX ER-retrieval signal. EMBO J. 14, 2250-2256.
21. Itin C., Roche A.C., Monsigny M. and Hauri H.P. (1996). ERGIC-53 is a functional mannose-selective and calcium-dependent human homologue of leguminous lectins. Mol. Biol. Cell 7, 483-493.
22. Kappeler F., Klopfenstein D.R., Foguet M., Paccaud J.P. and Hauri H.P. (1997). The recycling of ERGIC-53 in the early secretory pathway.ERGIC-53 carries a cytosolic endoplasmic reticulum-exit determinant interacting with COP II. J. Biol. Chem. 272, 31801-31808.
23. Kawasaki N., Ichikawa Y., Matsuo I., Totani K., Matsumoto N., Ito Y. and Yamamoto K. (2008). The sugar-binding ability of ERGIC-53 is enhanced by its interaction with MCFD2. Blood 111, 1972-1979.
24. Klumperman J., Schweizer A., Clausen H., Tang B.L., Hong W., Oorschot V. and Hauri H.P. (1998). The recycling pathway of protein ERGIC-53 and dynamics of the ER-Golgi intermediate compartment. J. Cell Sci. 11, 3411-3425.
25. Lahtinen U., Hellman U., Wernstedt C., Saraste J. and Pettersson R.F. (1996). Molecular cloning and expression of a 58-kDa cis-Golgi and intermediate compartment protein. J. Biol. Chem. 271, 4031-4037.
26. Lee T.H. and Linstedt A.D. (1999). Osmotically induced cell volume changes alter anterograde and retrograde transport, Golgi structure, and COPI dissociation. Mol. Biol. Cell 10, 1445-1462.
27. Lievens P.M., De Servi B., Garofalo S., Lunstrum G.P., Horton W.A. and Liboi E. (2008). Transient dimerization and interaction with ERGIC-53 occur in the fibroblast growth factor receptor 3 early secretory pathway. Int. J. Biochem. Cell Biol. 40, 2649-2659.
28. Lippincott-Schwartz J., Donaldson J.G., Schweizer A., Berger E.G., Hauri H.P., Yuan L.C. and Klausner R.D. (1990). Microtubuledependent retrograde transport of proteins into the ER in the presence of brefeldin A suggests an ER recycling pathway. Cell 60, 821-836.
29. Liu Y., Choudhury P., Cabral C.B. and Sifers N. (1999). Oligosaccharide modification in the early secretory pathway directs the selection of a misfolded glycoprotein for degradation by the proteasome. J. Biol. Chem. 274, 5861-5867.
30. Mattioli L., Anelli T., Fagioli C., Tacchetti C., Sitia R. and Valetti C. (2006). ER storage diseases: a role for ERGIC-53 in controlling the formation and shape of Russell bodies. J. Cell Sci. 119, 2532-2541.
31. Mohanty D., Ghosh K., Shetty S., Spreafico M., Garagiola I. and Peyvandi F. (2005). Mutations in the MCFD2 gene and a novel mutation in the LMAN1 gene in Indian families with combined deficiency of factor V and VIII. Am. J. Hematol. 79, 262-266.
32. Morais V.A., Brito C., Pijak D.S., Crystal A.S., Fortna R.R., Li T., Wong P.C., Doms R.W. and Costa J. (2006). N-glycosylation of human nicastrin is required for interaction with the lectins from the secretory pathway calnexin and ERGIC-53. Biochim. Biophys. Acta 1762, 802-881.
33. Neerman-Arbez M., Johnson K.M., Morris M.A., McVey J.H., Peyvandi F., Nichols W.C., Ginsburg D., Rossier C., Antonarakis S.E. and Tuddenham E.G. (1999). Molecular analysis of the ERGIC-53 gene in 35 families with combined factor V-factor VIII deficiency. Blood 93, 2253-2260.
34. Neve E.P., Svensson K., Fuxe J. and Pettersson R.F. (2003). VIPL, a VIP36-like membrane protein with a putative function in the export of glycoproteins from the endoplasmic reticulum. Exp. Cell Res. 288, 70-83.
35. Neve E.P., Lahtinen U, and Pettersson R.F. (2005). Oligomerization and interacellular localization of the glycoprotein receptor ERGIC-53 is independent of disulfide bonds. J. Mol. Biol. 354, 556-568.
36. Nichols W.C., Seligsohn U., Zivelin A., Terry V.H., Hertel C.E., Wheatley M.A., Moussalli M.J., Hauri H.P., Ciavarella N., Kaufman R.J. and Ginsburg D. (1998). Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell 93, 61-70.
37. Nichols W.C., Terry V.H., Wheatley M.A., Yang A., Zivelin A., Ciavarella N., Stefanile C., Matsushita T., Saito H., de Bosch N.B., Ruiz-Saez A., Torres A., Thompson A.R., Feinstein D.I., White G.C., Negrier C., Vinciguerra C., Aktan M., Kaufman R.J., Ginsburg D. and Seligsohn U. (1999). ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency families. Blood 93, 2261-2266.
38. Nufer O., Guldbrandsen S., Degen M., Kappeler F., Paccaud J.P., Tani K. and Hauri H.P. (2002). Role of cytoplasmic C-terminal amino acids of membrane proteins in ER export. J. Cell Sci. 115, 619-628.
39. Nufer O., Kappeler F., Guldbrandsen S. and Hauri H.P. (2003a). ER export of ERGIC-53 is controlled by cooperation of targeting determinants in all three of its domains. J. Cell Sci. 116, 4429-4440.
40. Nufer O., Mitrivic S. and Hauri H.P. (2003b). Profile-based Data Base Scanning for Animal L-type Lectins and Characterization of VIPL, a Novel VIP36-like Endoplasmic Reticulum Protein. J. Biol. Chem. 278, 15886-15896.
41. Nyfeler B., Nufer O., Matsui T., Mori K. and Hauri H.P. (2003). The cargo receptor ERGIC-53 is a target of the unfolded protein response. Biochem. Biophys. Res. Commun. 304, 599-604.
42. Nyfeler B., Zhang B., Ginsburg D., Kaufman R.J. and Hauri H.P. (2006). Cargo Selectivity of the ERGIC-53/MCFD2 Transport Receptor Complex. Traffic 7, 1473-1481.
43. Nyfeler B., Reiterer V., Wendeler M.W., Stefan E., Zhang B., Michnick S.W. and Hauri H.P. (2008a). Identification of ERGIC-53 as an intracellular transport receptor of alpha1-antitrypsin. J. Cell Biol. 180, 705-712.
44. Nyfeler B., Kamiya Y., Boehlen F., Yamamoto K., Kato K., de Moerloose P., Hauri H.P. and Neerman-Arbez M. (2008b). Deletion of 3 residues from the C-terminus of MCFD2 affects binding to ERGIC-53 and causes combined factor V and factor VIII deficiency. Blood 111, 1299-1301.
45. Oeri J., Matter M., Isenschmid H., Hauser F. and Koller F. (1954). Angeborener mangel an factor V (parahaemophilie) verbunden mit echter haemophilie A bein zwei brudern. Med. Probl. Paediatr. 1, 575-588.
46. Olivari S., Galli C., Alanen H., Ruddock L. and Molinari M. (2005). A Novel stress-induced EDEM variant regulating endoplasmic reticulum-associated glycoprotein degradation. J. Biol. Chem. 280, 2424-2428.
47. Olivari S., Cali T., Salo K.E., Paganetti P., Ruddock L.W. and Molinari M. (2006). EDEM1 regulates ER-associated degradation by accelerating de-mannosylation of folding-defective polypeptides and by inhibiting their covalent aggregation. Biochem. Biophys. Res. Commun. 349, 1278-1284.
48. Palokangas H., Ying M., Väänänen K. and Saraste J. (1999). Retrograde transport from the pre-Golgi intermediate compartment and the Golgi complex is affected by the vacuolar H+-ATPase inhibitor bafilomycin A1. Mol. Biol. Cell 8, 3561-3578.
49. Pryde J., Farmaki T. and Lucocq J.M. (1998). Okadaic acid induces selective arrest of protein transport in the rough endoplasmic reticulum and prevents export into COPII-coated structures. Mol. Cell Biol. 18, 1125-1135.
50. Renna M., Caporaso M.G., Bonatti S., Kaufman R.J. and Remondelli P. (2007). Regulation of ERGIC-53 gene transcription in response to endoplasmic reticulum stress. J. Biol. Chem. 282, 22499-22512.
51. Roy B. and Lee A.S. (1999). The mammalian endoplasmic reticulum stress response element consists of an evolutionarily conserved tripartite structure and interacts with a novel stress-inducible complex. Nucleic. Acids Res. 27, 1437-1443.
52. Saraste J. and Svensson K. (1991). Distribution of the intermediate elements operating in ER to Golgi transport. J. Cell Sci. 100, 415-430.
53. Satoh T., Sato K., Kanoh A., Yamashita K., Yamada Y., Igarashi N., Kato R., Nakano A. and Wakatsuki S. (2006) Structures of the carbohydrate recognition domain of Ca2+-independent cargo receptors Emp46p and Emp47p. J. Biol. Chem. 281, 10410-10419.
54. Schindler R., Itin C., Zerial M., Lottspeich F. and Hauri H.P. (1993). ERGIC-53, a membrane protein of the ER-Golgi intermediate compartment, carries an ER retention motif. Eur. J. Cell Biol. 61, 1-9.
55. Segal A., Zivelin A., Rosenberg N., Ginsburg D., Shpilberg O. and Seligsohn U. (2004). A mutation in LMAN1 (ERGIC-53) causing combined factor V and factor VIII deficiency is prevalent in Jews originating from the island of Djerba in Tunisia. Blood Coagul. Fibrinolysis 15, 99-102.
56. Seligsohn U., Zivelin A. and Zwang E. (1982). Combined factor V and factor VIII deficiency among non-Ashkenazi Jews. N. Engl. J. Med. 307, 1191-1195.
57. Shima D.T., Cabrera-Poch N., Pepperkok R. and Warren G. (1998). An ordered inheritance strategy for the Golgi apparatus: visualization of mitotic disassembly reveals a role for the mitotic spindle. J. Cell Biol. 141, 955-966.
58. Sirachainan N., Zhang B., Chuansumrit A. and Pipe S. (2005). Combined factor V and factor VIII deficiency in a Thai patient: a case report of genotype and phenotype characteristics. Haemophilia 11, 280-284.
59. Spatuzza C., Renna M., Faraonio R., Cardinali G., Martire G., Bonatti S. and Remondelli P. (2004). Heat shock induces preferential translation of ERGIC-53 and affects its recycling pathway. J. Biol. Chem. 279, 42535-42544.
60. Velloso L.M., Svensson K., Schneider G., Pettersson R.F. and Lindqvist Y. (2002). Crystal structure of the carbohydrate recognition domain of p58/ERGIC-53, a protein involved in glycoprotein export from the endoplasmic reticulum. J. Biol. Chem. 277, 15979-15984.
61. Velloso L.M., Svensson K., Pettersson R.F. and Lindqvist Y. (2003). The crystal structure of the carbohydrate-recognition domain of the glycoprotein sorting receptor p58/ERGIC-53 reveals an unpredicted metal-binding site and conformational changes associated with calcium ion binding. J. Mol. Biol. 334, 845-851.
62. Vollenweider F., Kappeler F., Itin C. and Hauri H.P. (1998). Mistargeting of the lectin ERGIC-53 to the endoplasmic reticulum of HeLa cells impairs the secretion of a lysosomal enzyme. J. Cell Bio. 142, 377-389.
63. Yoshida H., Haze K., Yanagi H., Yura T. and Mori K. (1998). Identification of the cis-acting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucose-regulated proteins. J. Biol. Chem. 273, 33741-33749.
64. Zhang B., Cunningham M.A., Nichols W.C., Bernat J.A., Seligsohn U., Pipe S.W., McVey J.H., Schulte-Overberg U., de Bosch N.B., RuizSaez A., White G.C., Tuddenham E. G., Kaufman R.J. and Ginsburg D. (2003). Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex. Nat. Genet. 34, 220-225.
65. Zhang B. and Ginsburg D. (2004). Familial multiple coagulation factor deficiencies: new biologic insight from rare genetic bleeding disorders. J. Thromb. Haemost. 2, 1564-1572.
66. Zhang B., Kaufman R.J. and Ginsburg D. (2005). LMAN1 and MCFD2 form a cargo receptor complex and interact with coagulation factor VIII in the early secretory pathway. J. Biol. Chem. 280, 25881-25886.
67. Zhang B., McGee B., Yamaoka J.S., Guglielmone H., Downes K.A., Minoldo S., Jarchum G., Peyvandi F., Bosch N.B., Ruiz-Saez A., Chatelain B., Olpinski M., Bockenstedt P., Sperl W., Kaufman R.J., Nichols W.C., Tuddenham E.G.D. and Ginsburg D. (2006). Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2. Blood 107,1903-1907.
68. Zuker M. (2003). Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31, 3406-3415.